Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence
Version of Record online: 1 DEC 2011
© 2011 International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis
Volume 9, Issue 12, pages 2436–2446, December 2011
How to Cite
VANASSCHE, T., VERHAEGEN, J., PEETERMANS, W. E., VAN RYN, J., CHENG, A., SCHNEEWIND, O., HOYLAERTS, M. F. and VERHAMME, P. (2011), Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. Journal of Thrombosis and Haemostasis, 9: 2436–2446. doi: 10.1111/j.1538-7836.2011.04529.x
- Issue online: 1 DEC 2011
- Version of Record online: 1 DEC 2011
- Accepted manuscript online: 10 OCT 2011 05:40AM EST
- Received 11 June 2011, accepted 22 September 2011
Figure S1. Crystal violet staining with additional control conditions.
Figure S2. Myeloperoxidase (MPO) quantification in the presence of fibrin.
|JTH_4529_sm_fig1.tiff||215K||Supporting info item|
|JTH_4529_sm_fig2.tiff||46K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.